CNBX Pharms (CNBX) Stock Price, News & Analysis
Company Description
CNBX Pharms (OTC Link: CNBX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $160.6K.
On a trailing twelve-month basis, CNBX Pharms reported revenue of $0 and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for CNBX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CNBX Pharms (CNBX) stock last traded at $0.0000, down 99.00% from the previous close. At a market capitalization of $160.6K, CNBX is classified as a micro-cap stock with approximately 1.6B shares outstanding.
CNBX Rankings
Latest News
CNBX Pharms has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, clinical trial. View all CNBX news →
SEC Filings
CNBX Pharms has filed 5 recent SEC filings, including 2 Form 10-Q, 2 Form SCHEDULE 13G/A, 1 Form 8-K. The most recent filing was submitted on June 24, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CNBX SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in CNBX Pharms (CNBX) currently stands at 283.2 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has increased by 90.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for CNBX Pharms (CNBX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CNBX Company Profile & Sector Positioning
CNBX Pharms (CNBX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CNBX often look at related companies in the same sector, including PaxMedica, Inc. (PXMD), Marizyme (MRZM), Bassline Productions Inc (BSSP), Itoco Inc (ITMC), and Navidea Biopharm (NAVB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNBX's relative position within its industry.